Irinotecan and docetaxel as first line chemotherapy in patients with stage IIIB/IV non-small cell lung cancer - experience from a prematurely closed phase II study

被引：8
|
作者：
Raez, LE [1 ]
Rosado, MF [1 ]
Santos, ES [1 ]
Reis, IM [1 ]
机构：
[1] Univ Miami, Sch Med, Sylvester Comprehens Canc Ctr, Div Hematol Oncol, Miami, FL 33136 USA
来源：
LUNG CANCER | 2004年 / 45卷 / 01期
关键词：
D O I：
10.1016/j.lungcan.2004.01.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：131 / 132
页数：2
相关论文
共 50 条
  • [21] A phase I/II trial of weekly docetaxel and gefitinib in elderly patients (≥70) with stage IIIB/IV non-small cell lung cancer (NSCLC)
    Stinchcombe, T
    Socinski, M
    Choksi, J
    Bakri, K
    Taylor, M
    Tynan, M
    Mears, A
    Smith, C
    LUNG CANCER, 2005, 49 : S270 - S270
  • [22] A phase II study of oxaliplatin and gemcitabine in advanced inoperable stage IIIB/IV non-small cell lung cancer
    McLaren, V.
    Graham, J.
    Paul, J.
    Dunlop, D.
    CLINICAL ONCOLOGY, 2008, 20 (05) : 384 - 385
  • [23] Oxaliplatin and docetaxel as first line chemotherapy for patients with non-small cell lung cancer (NSCLC).
    Santos, ES
    Raez, LE
    Rocha-Lima, C
    Tolba, K
    Negret, L
    Farfan, N
    Decesare, T
    Lopes, G
    Rosado, MF
    Wu, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 687S - 687S
  • [24] Procalcitonin serum levels in patients with stage IV non-small cell lung cancer in first line of chemotherapy
    Garoutte, Camille
    Poulet, Claire
    Obstler, Jean Baptiste
    Bourgeois, Anne-Marie
    Khamis, Warda
    Dewolf, Maxime
    Faouzi, Sara
    Galmiche, Antoine
    Jounieaux, Vincent
    Andrejak, Claire
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [25] Phase II study of docetaxel (Taxotere®) of 75 mg/m2 in Chinese patients with stage IIIB/IV non-small cell lung cancer (NSCLC)
    Sun, Y
    Zhang, XR
    Li, WL
    Guan, ZZ
    Li, LQ
    Zhai, Y
    ANNALS OF ONCOLOGY, 1998, 9 : 99 - 99
  • [26] A phase II study of weekly gemcitabine and paclitaxel in patients with previously untreated stage IIIb and IV non-small cell lung cancer
    Bhatia, S
    Hanna, N
    Ansari, R
    Pletcher, W
    Einhorn, L
    Ng, E
    Sandler, A
    LUNG CANCER, 2002, 38 (01) : 73 - 77
  • [27] Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer:: a lung cancer Galician group phase II study
    Casal, Joaquin
    Amenedo, Margarita
    Mel, Jose Ramon
    Anton, Luis Miguel
    Rodriguez-Lopez, Ruben
    Lopez-Lopez, Rafael
    Gonzalez-Ageitos, Ana
    Castellanos, Javier
    Constenla, Manuel
    Tisaire, Jose L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (05) : 725 - 732
  • [28] Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study
    Joaquín Casal
    Margarita Amenedo
    José Ramón Mel
    Luis Miguel Antón
    Rubén Rodríguez-López
    Rafael López-López
    Ana González-Ageitos
    Javier Castellanos
    Manuel Constenla
    José L. Tisaire
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 725 - 732
  • [29] Phase II trial of sequential bevacizumab (B), erlotinib (E) and chemotherapy for first line treatment of clinical stage IIIB or IV non-small cell lung cancer (NSCLC)
    Faoro, L.
    Cohen, E. E.
    Govindan, R.
    Kozloff, M. F.
    Hoffman, P. C.
    Maitland, M. L.
    Verel, K.
    Szeto, L.
    Salgia, R.
    Vokes, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] Therapy for stage IIIB and stage IV non-small cell lung cancer
    Kim, TE
    Murren, JR
    CLINICS IN CHEST MEDICINE, 2002, 23 (01) : 209 - +
12345